‹ All stocks

Apollomics

APLM · NASDAQ · Healthcare

$24.26

▲ $24.26 (3.59%)

1D 7D 1M 3M 1Y All

Day range

$22.50 – $24.26

Year range

$10.01 – $42.12

Open

$23.42

Previous close

—

Market cap

$53.28M

Volume (24h)

$68

Volume (52w)

$1.65K

Performance

▲ 1.72%

▼ -0.98%

▲ 28.16%

▲ 57.53%

▲ 31.63%

YTD

▲ 25.70%

▼ -91.78%

▼ -97.55%

All-time

▼ -97.55%

Key statistics

P/E ratio

-0.68

EPS (TTM)

$-35.86

Dividend yield

—

Dividend (TTM)

—

Payout ratio

—

Shares outstanding

2.2M

About Apollomics

Apollomics, Inc. functions as a clinical-phase biotechnology enterprise, concentrating its efforts on discovering and advancing novel cancer treatments to meet crucial, underserved patient requirements. The company was co-founded by Liang Yu Guo and Sanjeev Redkar in 2015, with its main operations based in Foster City, California.

Visit website

Country: United States of America

LLY Eli Lilly and Company	$1156.42	0.49%
JNJ Johnson & Johnson	$254.52	-0.58%
ABBV AbbVie	$262.04	0.29%
MRK Merck & Co.	$139.70	-2.76%
UNH UnitedHealth Group Incorp…	$371.61	-0.19%